RECURRENT PLEURAL MALIGNANT MESOTHELIOMA

Clinical trials for RECURRENT PLEURAL MALIGNANT MESOTHELIOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT PLEURAL MALIGNANT MESOTHELIOMA trials appear

Sign up with your email to follow new studies for RECURRENT PLEURAL MALIGNANT MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 2 Completed 1

Immune drug shows promise against rare cancer

Disease control Completed

This study tested the drug pembrolizumab in 65 people with malignant mesothelioma, a rare cancer of the lining around the lungs or abdomen. The drug works by helping the immune system attack cancer cells. The goal was to see if it could control the disease in patients whose cance…

Matched conditions: RECURRENT PLEURAL MALIGNANT MESOTHELIOMA

Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control

Last updated May 17, 2026 13:59 UTC

RECURRENT PLEURAL MALIGNANT MESOTHELIOMA

Get alerted when new RECURRENT PLEURAL MALIGNANT MESOTHELIOMA trials appear

Immune drug shows promise against rare cancer